Tag: Macular Degeneration
GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
More than twofold increased risk seen for nAMD development in unadjusted and adjusted models
Low, High HDL Linked to Risk for Age-Related Macular Degeneration
LPA was identified as a novel single nucleotide polymorphism that is associated with increased risk for AMD
Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting
Findings seen for patients being treated for neovascular age-related macular degeneration or diabetic macular edema
Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis
Findings seen after adjusting for lifestyle factors and comorbidities
Socioeconomic Factors Increase Risk for Age-Related Macular Degeneration
However, a healthy lifestyle can mitigate some of the risks associated with low socioeconomic status
Micronutrient Supplementation Slows Geographic Atrophy Progression
In eyes with noncentral GA, proximity-based progression toward central macula was slower with randomization to antioxidants
Melatonin Use Linked to Reduced Risk for Development, Progression of AMD
Melatonin use linked to reduced risk for developing AMD and for progression from nonexudative to exudative AMD
Home Vision Tests Offer Limited Diagnostic Accuracy for Neovascular AMD
Hospital eye service follow-up clinics maintain better diagnostic accuracy for active lesions
Outdoor Artificial Light at Night Tied to New Exudative AMD
Association found to be stronger with higher levels of exposure, but only significant in urban areas
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point